Our Report are designed to provide the best healthcare services.

Treatment is changing rapidly. Traditional approaches are increasingly complemented by targeted biologics, immune-modulating medicines, digital monitoring tools, advanced imaging, and personalized treatment strategies. The growing focus on early ...

The US life sciences industry is entering a period of rapid change, driven by advances in biotechnology, artificial intelligence, genomics and personalized medicine. According to Payal Rabde, a life sciences researcher specializing in biotechnol...

The U.S. next generation sequencing sector was valued at USD 3.3 billion in 2026 and is projected to reach USD 12.52 billion by 2035, expanding at a 15.95% CAGR from 2026 to 2035. Key Highlights Sequencing instruments held the leading product...

...

The US life sciences industry is entering a period of rapid change, driven by advances in biotechnology, artificial intelligence, genomics and personalized medicine. According to Payal Rabde, a life sciences researcher specializing in biotechnol...

Cell and gene therapy is quickly becoming one of the most closely watched areas in healthcare, and the numbers show why. The industry was valued at around USD 8.94 billion in 2025 and is expected to reach USD 10.44 billion in 2026. By 2035, it could...

The U.S. next generation sequencing sector was valued at USD 3.3 billion in 2026 and is projected to reach USD 12.52 billion by 2035, expanding at a 15.95% CAGR from 2026 to 2035. Key Highlights Sequencing instruments held the leading pro...

Cold plasma technology is gaining attention far beyond research laboratories, with healthcare, food processing and advanced manufacturing increasingly exploring what it can do. The global industry was valued at around USD 3.34 billion in 2025 an...

Cold plasma technology is gaining attention far beyond research laboratories, with healthcare, food processing and advanced manufacturing increasingly exploring what it can do. The global industry was valued at around USD 3.34 billion in 2025 an...